Skip to content
basque.press imagotipo logo basque press
Menu
  • · News · Noticias · Albisteak · Informations · Basque Country · País Vasco · Pays Basque · Euskal Herria ·
Menu
Ana Arrieta, Fernando Cossio, Quimatryx

The basque-based company Quimatryx licenses a cancer drug for 92 million dollars / La empresa Quimatryx licencia un fármaco contra el cáncer por 92 millones de dólares.

Posted on July 29, 2022July 30, 2022 by BP

Quimatryx’s compound has demonstrated high efficacy in solid tumours, such as pancreatic cancer, and blood tumours, such as mantle cell lymphoma.

El compuesto de Quimatryx ha demostrado una alta eficacia en tumores sólidos, como cáncer de páncreas, y tumores sanguíneos, como el linfoma de células del manto.

The basque-based company Quimatryx, which is developing a new drug for the treatment of cancers, has reached an agreement with a Chinese company for up to $92 million. Under the agreement, HiDiamond will carry out the entire regulatory pre-clinical phase and will also apply to the Chinese Medicines Agency for authorisation to carry out clinical trials of Quimatryx’s drug in China.

The agreement reached by Quimatryx marks a major breakthrough in the development of the drug, as it is a licence that includes payments of up to 92 million dollars, linked to the achievement of both development and commercial milestones, plus royalties on sales. It also means the consolidation of Quimatryx as a benchmark in drug development and highlights the potential and capacity of the pharmaceutical sector in the Basque Country.

Quimatryx’s compound is an epigenetic drug that has already demonstrated high efficacy in solid tumours, such as pancreatic and lung cancer, and blood cancers, such as mantle cell lymphoma.

The agreement places Quimatryx and the Oncomatryx group as benchmark companies in the sector, representing an important income to continue the development of new compounds.

How Quimatryx’s compound works

The Quimatryx compound is a drug that corrects the alterations that cause diseases and helps to combat them by blocking epigenetic targets, which are proteins responsible for controlling and regulating genetics. One of the great advantages of this type of drug is that, unlike classic chemotherapy, which attacks both malignant and healthy cells, epigenetic therapy is more targeted and more specific in the way it acts, so it only attacks tumour cells, causing less toxicity in the patient.

About Quimatryx

Quimatryx, part of the Oncomatryx Group, is a company that discovers and develops new drugs against epigenetic targets until their validation in Clinical Phase I for different diseases such as cancer or neurodegenerative diseases, for subsequent licensing to a pharmaceutical company.

The origin of QUIMATRYX is in a research carried out by Professors Ana Arrieta and Fernando Cossio and other researchers at the University of the Basque Country (UPV/EHU), which generated a spin off, which in 2015 joined the Oncomatryx Group.

Quimatryx has been able to reach this agreement with the collaboration of Dr. Tianke Wong from the Swiss consultancy Dao Tun.

About HiDiamond

Hidiamond is a Chinese R&D company focused on cutting-edge biomedical products, aiming to develop world-leading therapeutic products.

Leveraging on its founding shareholders’ in-depth knowledge of industry policies and regulatory standards, as well as the advantages of its experts and resources in the fields of drug registration, clinical research and technical review, Hidiamond takes full advantage of the global competitiveness of the comprehensive efficiency and cost of Chinese pharmaceutical research and development to innovate and develop advanced therapeutic products in tune with the world and even world leaders, in order to meet the unmet medical needs of patients around the world.

Hidiamond focuses on the research and development of global advanced therapeutics, firm-in-class innovative targets and/or mechanisms, and fast-follow and best-in-class innovative molecular entities with verified targets and/or mechanisms.

El compuesto de Quimatryx ha demostrado una alta eficacia en tumores sólidos, como cáncer de páncreas, y tumores sanguíneos, como el linfoma de células del manto.

La empresa de Gipuzkoa Quimatryx, que desarrolla un nuevo fármaco para el tratamiento de cánceres, ha llegado a un acuerdo con una empresa china por hasta 92 millones de dolares. En virtud de dicho acuerdo, la empresa HiDiamond desarrollará toda la fase preclínica regulatoria y, además, solicitará a la Agencia China del Medicamento autorización para realizar ensayos clínicos del fármaco de Quimatryx que llevará a cabo en el país asiático.

El acuerdo alcanzado por Quimatryx marca un destacado avance en el desarrollo del fármaco, ya que es una licencia que recoge unos pagos de hasta 92 millones de dólares, ligados a la consecución de hitos tanto de desarrollo como comerciales, más unos royalties sobre ventas. Además, supone la consolidación de Quimatryx como referente en el desarrollo de fármacos y pone en valor el potencial y la capacidad del sector farmacéutico del País Vasco.

El compuesto de Quimatryx es un fármaco epigenético que ya ha demostrado una elevada eficacia en tumores sólidos, como el cáncer de páncreas y el de pulmón, y en neoplasias sanguíneas, como el linfoma de células del manto.

El acuerdo alcanzado coloca a Quimatryx y al grupo Oncomatryx como empresas referentes del sector, suponiendo un importante ingreso para continuar el desarrollo de nuevos compuestos.

Funcionamiento del compuesto de Quimatryx

El compuesto de Quimatryx es un fármaco que corrige las alteraciones causantes de las enfermedades y ayuda a combatirlas, mediante el bloqueo de las dianas epigenéticas, que son aquellas proteínas encargadas de controlan y regular la genética. Una de las grandes ventajas de este tipo de fármacos es que, a diferencia de la quimioterapia clásica, que ataca tanto a células malignas como a las sanas, la terapia epigenética está más dirigida y es más específica en cuanto a su forma de actuar, por lo que ataca solo a las células tumorales, provocando menos toxicidad en el paciente.

Sobre Quimatryx

El origen de QUIMATRYX está en una investigación realizada por los Profesores Ana Arrieta y Fernando Cossio y otros investigadores en la Universidad del País Vasco (UPV/EHU), los cuales generaron una spin off, que en el año 2015 se incorporó al Grupo Oncomatryx.

Quimatryx ha contado para llegar a este acuerdo con la colaboración del Doctor Tianke Wong de la consultora suiza Dao Tun.

Sobre HiDiamond

Hidiamond es una empresa china de I+D centrada en productos biomédicos de vanguardia, cuyo objetivo es desarrollar productos terapéuticos líderes en el mundo.

Apoyándose en el profundo conocimiento de sus accionistas fundadores en materia de políticas industriales y normativas reguladoras, así como en las ventajas de sus expertos y recursos en los campos del registro de medicamentos, la investigación clínica y la revisión técnica, Hidiamond aprovecha al máximo la competitividad global de la eficiencia y el coste integrales de la investigación y el desarrollo farmacéuticos chinos, para innovar y desarrollar productos terapéuticos avanzados en sintonía con el mundo e incluso líderes mundiales, con el fin de satisfacer las necesidades médicas no cubiertas de los pacientes de todo el mundo.

Hidiamond se centra en la investigación y el desarrollo de productos terapéuticos avanzados globales, dianas y/o mecanismos innovadores firs-in-class, y entidades moleculares innovadoras fast follow y best-in-class con dianas y/o mecanismos verificados.

Search / Buscar / Bilatu

News · Noticias · Albisteak

  • Euskadi presents its Forest Bioeconomy strategy at the FIBC International Conference in Vancouver, Canada. May 15, 2025
  • Ikerbasque will promote the return of Basque researchers from the United States given the new political scenario May 11, 2025
  • Donostia -San Sebastián Moda Festival, Spring-Summer 2025 May 8, 2025
  • BeDIGITAL will hold its seventh edition at the BEC with the participation of leading companies and organisations April 30, 2025
  • WindEurope 2025: Euskadi – Basque Country showcased its wind energy capacity April 25, 2025
  • Artistic narrative through Basque mythology and folklore   April 11, 2025
  • Bilbao Hosts Food 4 Future: Europe’s Largest Food Innovation Congress April 9, 2025
  • From Donostia – San Sebastian to the world: the cheesecake that is causing a furor March 27, 2025
  • The President of the Basque Country visited the United States of America March 25, 2025
  • SKFK presents its Oreka collection at a Basque pelota court in Paris March 13, 2025
  • Deusto University celebrates de III International Congress on Law and Artificial Intelligence March 7, 2025
  • Singapore and the Basque Country explore new business opportunities in renewable energies and biosciences March 6, 2025
  • Euskadi strengthens its position in Germany with Bavaria as a base camp for internationalisation March 4, 2025
  • Arania accelerates its expansion with innovation, sustainability and digital transformation. February 28, 2025
  • The third edition of the Euskadi logistics congress has been held at BEC in February February 27, 2025
  • Basque companies will participate in the reconstruction of Ukraine February 25, 2025
  • The ASETT centre “Arizmendiarrieta Social Economy Think Tank” opens in Donostia – San Sebastián. February 20, 2025
  • Bilbao Slush’D 2025: Discover, Connect and Grow February 5, 2025
  • The Basque Country seeks to grow and strengthen its position on the international stage January 22, 2025
  • Polypal’s metal storage racks, present in more than 30 countries December 22, 2024
  • The Seenapse platform supports the professional inspiration of creativity December 4, 2024
  • Councillor Mikel Jauregi heads Basque Government institutional and business mission to Japan and Taiwan December 4, 2024
  • ALL IN ON BOARD COURIER: An innovative and pioneering solution in express logistics October 29, 2024
  • Cyber Human Systems launches industrial exoskeleton to minimize fatigue and risk of injury October 29, 2024
  • EIT Manufacturing and Global Factor join forces to boost sustainability in industry October 15, 2024
  • This is LUR-1, the first 100% Basque satellite launched by AVS October 11, 2024
  • Euskatfund provides technical solutions and productivity improvements for the foundry sector worldwide October 7, 2024
  • Lantek company increases revenue and strengthens its position as a global leader October 6, 2024
  • Arkaitz Etxezarreta: “The DUNE project is a major technological and manufacturing challenge for Erreka” October 3, 2024
  • Technology Centers, Universities and Institutions, present Biqain: ‘Bizkaia Quantum Advanced Industries’. September 19, 2024
  • The Basque Diaspora: 7th International Day September 17, 2024
  • Artificial Intelligence International Basque Forum September 7, 2024
  • The ‘Conscious Factory’: TECNALIA makes it a reality with a 15% increase in activity in industrial companies August 28, 2024
  • Irega exports 95% of its adjustable wrench production to international markets August 13, 2024
  • Join BIND’s open innovation program: Call for disruptive startups and scale-ups in Europe July 23, 2024
  • Entrepreneurship and Innovation in Food and Gastronomy: CIC Partners with Basque Culinary Center’s GOe–Gastronomy Open Ecosystem Initiative July 23, 2024
  • ‘Lanzo Batteries’: CIDETEC’s new company will manufacture batteries for space June 23, 2024
  • The new thermonuclear engine concept to power Europe’s space race May 29, 2024
  • Urbegi Social Impact: Transforming organizations and territories throught collaborative work April 28, 2024
  • The Passivhaus-style building with the highest accommodation capacity in Europe, designed by Basque professionals April 26, 2024
  • The Lehendakari, President of the Basque Government highlights the transformative power of the cultural and creative industries at the opening of the CWF24 April 16, 2024
  • The D’Elhuyar brothers: The discovery and isolation of tungsten April 13, 2024
  • Nominations are open for the 9th edition of the Basque Culinary Center world prize March 23, 2024
  • Basque Country Technology Park: the 1st technology park in the world powered by green hydrogen March 16, 2024
  • MUN Bilbao’ 2024, debates, solutions and union among young people of the world February 8, 2024
  • The World Economic Forum publishes in Davos the progress report on the “transition from industrial clusters to zero net emissions” initiative. January 26, 2024
  • “I am like a tree, with roots in a country and branches open to the world.”  Centenary of Eduardo Chillida. January 25, 2024
  • Euskadi reiterates its commitment to European industry at the tenth anniversary of the Vanguard Initiative network January 23, 2024
  • The Basque Government receives the international Catalyst 2030 award in London for its contribution to Agenda 2030 January 17, 2024
  • TECNALIA and FERSA Bearings join forces to implement Industry 5.0 in their European plants January 5, 2024

Categories

  • aeronautic
  • ANTIBIOTICS
  • Art
  • artificial intelligence
  • autism investigation
  • BASQUE COUNTRY
  • Basque government
  • BIO / Salud / Health / Osasuna
  • Business – Enpresak – Empresas
  • Culture / Cultura / Kultura
  • Education/Educación
  • engineering
  • entrepreneurial
  • environment
  • European Commission
  • industry
  • ingénierie
  • Innovation
  • Institutions / Erakundeak / Instituciones
  • International / Nazioartekoa / Internacional
  • Lifestyle / Estilo de Vida / Bizi-Estiloa
  • psychedelic disorders
  • public administration
  • Quality Innovation Award
  • Research / Ikerketa / Investigación / Science / Zientzia /Ciencia
  • space
  • STARTUP
  • sustainability
  • Technology
  • United Nations
  • UPV researchers
  • UPV/EHU
SPRI Group presents and World Manufacturing Forum
Iberdrola guggenheim
Polykey Polymers
Isozaki Atea Plaza de la Conviencia Puente Calatrava Abando
ISOZAKI Towers, Bilbao, Bizkaia
Gotongo
Torre Iberdrola Tower Building Torrea
IBERDROLA Energy, Bilbao, Bizkaia
Valdelana Familia
Culinary Action On the road Basque Center
BASQUE CULINARY ACTION
Nowport
Torre Iberdrola Guggenheim
Guggenheim Museum, Bilbao, Bizkaia
LOGOS Company. Gipuzkoa
Logos
LOGOS Company. Gipuzkoa
Health Bio Technologies
BIOLAN Health workers
TEKNIKER & GAIKER Alliance
Valdelana
LOGOS Company. Gipuzkoa
CIDETEC
Urkullu - CTP
Dan Ansotegui
ZIV
AZTI
Embajador de la Araucania
Inser Robótica
Touchlight
Grupo Unceta
Tekniker and GAIKER Partnership
Echemar
Charla del Lehendakari Urkully con el embajador de Cuba
HanHemen Han Hemen
Dancer
Lehendakari Urkullu con Mathias Geisen CEO de Mercedes-Benz Vans
BASQUEVOLT
7/6/2022 PARTIDO ACB PLAY OFF 3º PARTIDO BASKONIA-REAL MADRID
Atlantic Arc Commission
Arantxa Tapia MUBIL Euskadi
ProWein 2022 - Euskadi Basque Country
Basque Country Japon
Euskadi Basque Country 2025
Select USA - Basque Trade & Investment
One Ocean Summit
Polykey
IKERLAN
Basque Culinary World Prize
Lantek
MoU: Euskadi y Flandes
Roberto Otxandio Izagirre
Mantala
Zeuko
Alias Robotics
Arantxa Tapia Eusko Jaurlaritza Gobierno Vasco
atelier iinovation pays basque eskual herria
BAIC e IndesIA
Dubai Expo - MTA
AZTI and Agour
Lehendakari
Euskadi Net Cero
CIDETEC
Salva
Gobierno Vasco Arantxa Tapia Aingoa Ondarzabal Virginia Energía Cluster
EMO Milan
Ingemat
Mundura Begira 2021
Inzu Group
Metagra
Iberdrola
Ana Arrieta, Fernando Cossio, Quimatryx
Zubiola
Mondragon Assembly
Fundación Ashoka
COP26 Tapia
Euskal Diasporaren Eguna
Euskal DIASPORAren Eguna

Archives

  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021

Categories

  • aeronautic
  • ANTIBIOTICS
  • Art
  • artificial intelligence
  • autism investigation
  • BASQUE COUNTRY
  • Basque government
  • BIO / Salud / Health / Osasuna
  • Business – Enpresak – Empresas
  • Culture / Cultura / Kultura
  • Education/Educación
  • engineering
  • entrepreneurial
  • environment
  • European Commission
  • industry
  • ingénierie
  • Innovation
  • Institutions / Erakundeak / Instituciones
  • International / Nazioartekoa / Internacional
  • Lifestyle / Estilo de Vida / Bizi-Estiloa
  • psychedelic disorders
  • public administration
  • Quality Innovation Award
  • Research / Ikerketa / Investigación / Science / Zientzia /Ciencia
  • space
  • STARTUP
  • sustainability
  • Technology
  • United Nations
  • UPV researchers
  • UPV/EHU

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

About BASQUE.press

  • Ayudamos a crear y proyectar buenas noticias al Mundo.
  • Mundura berri onak sortzen eta proiektatzen laguntzea.
  • We help create and release good news to the world.

  • ¿Quiénes Somos?

 

Isozaki Atea / Plaza de la Convivencia.
48001 BILBAO / Euskadi / BASQUE COUNTRY
info@BASQUE.press

Tags · Etiketak · Etiquetas

Artificial Intelligence automoción Basque Companies Basque company Basque Country Basque Culture Basque government Basque Industry BEC Bilbao BIND 4.0 Bizkaia Business CIC energiGUNE Emprendimiento empresa vasca Energy Energía entrepreneurship Europe Euskadi France health Iberdrola Industry innovación Innovation internacional internacionalización international internationalization Japan Lehendakari Mondragon University País Vasco science SPRI Group Startup startups sustainability Technology Tecnología UPV/EHU Urkullu USA
basque press isotipo transp
© 2025 BASQUE.press | Powered by Superbs Personal Blog theme